A Biomimetic Leaflet Scaffold for Aortic Valve Remodeling
Source abstract
Abstract
Abstract Heart valve disease poses a significant clinical challenge, especially in pediatric populations, due to the inability of existing valve replacements to grow or respond biologically to their microenvironment. Tissue‐engineered heart valves (TEHVs) provide a solution by facilitating patient‐specific models for self‐repair and remodeling. In this study, a 3D‐bioprinted TEHV is designed to emulate the trilayer leaflet structure of an aortic valve. A cell‐laden hydrogel scaffold made from gelatin methacrylate and polyethylene glycol diacrylate (GelMA/PEGDA) incorporates valvular interstitial‐like (VIC‐like) cells, being reinforced with a layer of polycaprolactone (PCL). The composition of the hydrogel scaffold remains stable over 7 days, having increased mechanical strength compared to pure GelMA. The scaffold maintains VIC‐like cell function and promotes extracellular matrix (ECM) protein expression up to 14 days under two dynamic culture conditions: shear stress and stretching; replicating heart valve behavior within a more physiological‐like setting and suggesting remodeling potential via ECM synthesis. This TEHV offers a promising avenue for valve replacements, closely replicating the structural and functional attributes of a native aortic valve, leading to mechanical and biological integration through biomaterial–cellular interactions.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Cardiac Valve Diseases and Treatments · Cardiac and Coronary Surgery Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Wallace H. Coulter Department of Biomedical Engineering Emory University School of Medicine & Georgia Institute of Technology Atlanta GA 30322 USA
Division of Cardiology Department of Medicine Emory University Atlanta GA 30322 USA
Children's Heart Research & Outcomes (HeRO) Center Children's Healthcare of Atlanta & Emory University Atlanta GA 30322 USA
Funding
National Science Foundation
References (47)
Show source-provided references
1. 10.1016/S0140-6736(06)69208-810.1016/S0140-6736(06)69208-8 ↗
2. Bach D. S. · J. Heart Valve Dis. · 2007 · 16 · 362
3. c)Aortic Valve Disease.American Heart Association 2020.
4. 10.1038/ncpcardio011210.1038/ncpcardio0112 ↗
5. 10.1016/j.acvd.2012.02.01310.1016/j.acvd.2012.02.013 ↗
6. 10.1146/annurev-bioeng-061008-12490310.1146/annurev-bioeng-061008-124903 ↗
7. 10.1016/j.jsha.2013.11.00310.1016/j.jsha.2013.11.003 ↗
8. 10.1016/j.cjca.2021.03.02210.1016/j.cjca.2021.03.022 ↗
9. 10.1002/adhm.20170091810.1002/adhm.201700918 ↗
10. 10.1126/science.aav905110.1126/science.aav9051 ↗
11. 10.3390/nano805029610.3390/nano8050296 ↗
12. Maxson E. L. · Int. J. Bioprint. · 2019 · 1610.1016/j.bprint.2019.e00059 ↗
13. 10.1517/14712598.2015.105152710.1517/14712598.2015.1051527 ↗
14. 10.1007/s10439-016-1676-510.1007/s10439-016-1676-5 ↗
15. 10.1089/ten.a.2007.014810.1089/ten.a.2007.0148 ↗
16. 10.1007/s10439-016-1778-010.1007/s10439-016-1778-0 ↗
17. 10.1007/s10439-016-1607-510.1007/s10439-016-1607-5 ↗
18. 10.1016/j.actbio.2013.12.00510.1016/j.actbio.2013.12.005 ↗
19. 10.1615/JLongTermEffMedImplants.201501181710.1615/JLongTermEffMedImplants.2015011817 ↗
20. 10.1016/j.actbio.2018.02.02510.1016/j.actbio.2018.02.025 ↗
21. 10.1016/j.biomaterials.2020.11983810.1016/j.biomaterials.2020.119838 ↗
22. 10.22203/eCM.v006a0410.22203/eCM.v006a04 ↗
23. 10.1016/j.actbio.2011.02.01810.1016/j.actbio.2011.02.018 ↗
24. 10.1161/01.RES.0000136520.07995.aa10.1161/01.RES.0000136520.07995.aa ↗
25. 10.1016/j.matbio.2010.09.00110.1016/j.matbio.2010.09.001 ↗
26. 10.1089/teb.2007.015010.1089/teb.2007.0150 ↗
27. 10.1002/adhm.20160111810.1002/adhm.201601118 ↗
28. 10.2353/ajpath.2007.07025110.2353/ajpath.2007.070251 ↗
29. 10.1002/jbm.a.3613310.1002/jbm.a.36133 ↗
30. 10.1073/pnas.130636911010.1073/pnas.1306369110 ↗
31. 10.1089/ten.tea.2020.011810.1089/ten.tea.2020.0118 ↗
32. 10.1016/j.biomaterials.2019.11949310.1016/j.biomaterials.2019.119493 ↗
33. 10.1016/j.biomaterials.2014.04.03910.1016/j.biomaterials.2014.04.039 ↗
34. 10.1002/adma.20130101610.1002/adma.201301016 ↗
35. 10.1002/adma.20130550610.1002/adma.201305506 ↗
36. 10.1016/0021-9290(92)90249-Z10.1016/0021-9290(92)90249-Z ↗
37. 10.1161/01.RES.47.5.79210.1161/01.RES.47.5.792 ↗
38. 10.3389/fcvm.2022.97573210.3389/fcvm.2022.975732 ↗
39. 10.1161/JAHA.117.00633910.1161/JAHA.117.006339 ↗
40. 10.1006/jsre.1994.110210.1006/jsre.1994.1102 ↗
41. 10.1152/ajpcell.00137.200710.1152/ajpcell.00137.2007 ↗
42. 10.1161/hc4601.09948910.1161/hc4601.099489 ↗
43. 10.1002/term.183610.1002/term.1836 ↗
44. 10.1038/s41598-018-25851-510.1038/s41598-018-25851-5 ↗
45. 10.3390/jcdd203021410.3390/jcdd2030214 ↗
46. 10.1002/adhm.20180067210.1002/adhm.201800672 ↗
47. 10.1002/adbi.20230012410.1002/adbi.202300124 ↗